Gateway Investment Advisers’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$213K Sell
1,003
-383
-28% -$75.2K ﹤0.01% 761
2026
Q1
$272K Buy
+1,386
New +$269K ﹤0.01% 635
2020
Q1
Sell
-89,577
Closed -$9.57M 526
2019
Q4
$9.57M Sell
89,577
-3,707
-4% -$387K 0.09% 191
2019
Q3
$9.98M Sell
93,284
-21,137
-18% -$2.17M 0.1% 184
2019
Q2
$11.6M Sell
114,421
-292
-0.3% -$28.1K 0.11% 173
2019
Q1
$10.3M Sell
114,713
-370
-0.3% -$32.1K 0.09% 192
2018
Q4
$9.58M Hold
115,083
0.09% 192
2018
Q3
$12.4M Sell
115,083
-231
-0.2% -$25.3K 0.1% 179
2018
Q2
$12.7M Sell
115,314
-729
-0.6% -$75.9K 0.11% 177
2018
Q1
$11.6M Sell
116,043
-25,354
-18% -$2.6M 0.1% 184
2017
Q4
$13.9M Sell
141,397
-4,848
-3% -$460K 0.12% 176
2017
Q3
$13.7M Sell
146,245
-8,458
-5% -$898K 0.12% 171
2017
Q2
$17.2M Buy
154,703
+8,982
+6% +$950K 0.15% 152
2017
Q1
$14.3M Buy
145,721
+6,316
+5% +$602K 0.13% 166
2016
Q4
$12.8M Sell
139,405
-27,529
-16% -$2.37M 0.12% 175
2016
Q3
$14.1M Sell
166,934
-51,446
-24% -$4.32M 0.13% 179
2016
Q2
$17.8M Sell
218,380
-16,644
-7% -$1.27M 0.15% 160
2016
Q1
$16.8M Sell
235,024
-3,717
-2% -$249K 0.15% 167
2015
Q4
$17M Buy
238,741
+55,629
+30% +$3.74M 0.14% 161
2015
Q3
$11.3M Sell
183,112
-1,203
-0.7% -$84.1K 0.1% 193
2015
Q2
$13.4M Sell
184,315
-226
-0.1% -$16.7K 0.11% 179
2015
Q1
$14.2M Sell
184,541
-160
-0.1% -$11.5K 0.12% 181
2014
Q4
$12.4M Buy
184,701
+56,014
+44% +$3.53M 0.1% 192
2014
Q3
$7.81M Buy
128,687
+33,519
+35% +$2.07M 0.06% 234
2014
Q2
$5.58M Buy
95,168
+2,130
+2% +$125K 0.04% 275
2014
Q1
$5.39M Buy
93,038
+76,972
+479% +$4.13M 0.04% 263
2013
Q4
$860K Sell
16,066
-1,350
-8% -$80.1K 0.01% 547
2013
Q3
$1.08M Buy
17,416
+1,164
+7% +$69.7K 0.01% 502
2013
Q2
$985K Buy
+16,252
New +$968K 0.01% 492

Other funds holding DGX

Gateway Investment Advisers's DGX Position: Q2 2026 in Review

Gateway Investment Advisers reduced its Quest Diagnostics (DGX) stake by 28% in Q2 2026, selling an estimated $75.2K and leaving 1,003 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #761.

Gateway Investment Advisers first reported a position in DGX in Q2 2013 and has held it in 29 quarters since. The position peaked at $17.8M in Q2 2016. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Gateway Investment Advisers held 1,003 shares of Quest Diagnostics worth $213K as of Q2 2026.
  • Gateway Investment Advisers sold 383 Quest Diagnostics shares in Q2 2026, an estimated $75.2K.
  • Quest Diagnostics made up ﹤0.01% of Gateway Investment Advisers's portfolio in Q2 2026, its #761 holding.
  • Gateway Investment Advisers first reported a position in Quest Diagnostics in Q2 2013 and has held it in 29 quarters since.
  • Gateway Investment Advisers's Quest Diagnostics position peaked at $17.8M in Q2 2016.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Gateway Investment Advisers's 13F filing for Q2 2026, filed 20 Jul 2026.